Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients

Journal of Periodontal Research

Volumn 45, Issue 4, 2010, Pages 471-480

  Ando, E S ^a   De Gennaro, L A ^b   Faveri, M ^a,c   Feres, M ^c   DiRienzo, J M ^d   Mayer, Marcia Pinto Alves ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c University of Guarulhos   (Brazil)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Cytolethal distending toxin; Enzyme linked immunosorbent assay (ELISA); Immunoglobulin G; Serotype

Indexed keywords

BACTERIAL TOXIN; BACTERIUM ANTIBODY; CYTOLETHAL DISTENDING TOXIN, ACTINOBACILLUS ACTINOMYCETEMCOMITANS; IMMUNOGLOBULIN G; MUTAGENIC AGENT; PROTEIN SUBUNIT;

ADOLESCENT; ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BLOOD; CELL SURVIVAL; CHO CELL; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; CRICETULUS; GINGIVA; GINGIVA BLEEDING; HAMSTER; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTITIS; SERODIAGNOSIS; SEROTYPING; TOOTH PLAQUE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CELL SURVIVAL; CHO CELLS; CHRONIC PERIODONTITIS; CRICETINAE; CRICETULUS; DENTAL PLAQUE; GINGIVA; GINGIVAL HEMORRHAGE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MIDDLE AGED; MUTAGENS; NEUTRALIZATION TESTS; PERIODONTAL POCKET; PERIODONTITIS; PROTEIN SUBUNITS; SEROTYPING; YOUNG ADULT;

EID: 77954839236     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01260.x     Document Type: Article

References (39)

1. Henderson B, Wilson M, Sharp L, Ward JM. Actinobacillus actinomycetemcomitans. J Med Microbiol 2002, 51:1013-1020.
2. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999, 20:136-167.
3. Wang D, Kawashima Y, Nagasawa T. Elevated serum IgG titer and avidity to Actinobacillus actinomycetemcomitans serotype c in Japanese periodontitis patients. Oral Microbiol Immunol 2005, 20:172-179.
4. Rylev M, Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 2008, 8(Suppl):346-361.
5. Mayer MP, Bueno LC, Hansen EJ, DiRienzo JM. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun 1999, 67:1227-1237.
6. Smith JL, Bayles DO. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 2006, 32:227-248.
7. Fernandes KP, Mayer MP, Ando ES, Ulbrich AG, Amarente-Mendes JG, Russo M. Inhibition of interferon-gamma-induced nitric oxide production in endotoxin-activated macrophages by cytolethal distending toxin. Oral Microbiol Immunol 2008, 23:360-366.
8. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 2006, 74:4496-4504.
9. Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001, 69:5925-5930.
10. Xu T, Lundqvist A, Ahmed HJ, Eriksson K, Yang Y, Lagergard T. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4 + T cells. Microbes Infect 2004, 6:1171-1181.
11. Lewis DA, Stevens MK, Latimer JL. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun 2001, 69:5626-5634.
12. Fox JG, Rogers AB, Whary MT. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 2004, 72:1116-1125.
13. Purdy D, Buswell CM, Hodgson AE, McAlpine K, Henderson I, Leach SA. Characterization of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J Med Microbiol 2000, 49:473-479.
14. Mbwana J, Ahmed HJ, Ahlman K. Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid. Microb Pathog 2003, 35:133-137.
15. Xynogala I, Volgina A, DiRienzo JM, Korostoff J. Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis. Oral Microbiol Immunol 2009, 24:116-123.
16. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999, 4:1-6.
17. Faveri M, Mayer MP, Feres M, de Figueiredo LC, Dewhirst FE, Paster BJ. Microbiological diversity of generalized aggressive periodontitis by 16S rRNA clonal analysis. Oral Microbiol Immunol 2008, 23:112-118.
18. Mao X, DiRienzo JM. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol 2002, 4:245-255.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
20. Ebersole JL, Frey DE, Taubman MA, Smith DJ. An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans. J Periodontal Res 1980, 15:621-632.
21. Deshpande SS. Assay Development, Evaluation, and Validation. Enzyme Immunoassays from Concept to Product Development 1996, 343-349. Deshpande SS. ed, New York, Chapman & Hall
22. Faveri M, Figueiredo LC, Duarte PM, Mestnik MJ, Mayer MPA, Feres M. Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol 2009, 36:739-749.
23. Vilkuna-Rautiainen T, Pussinen PJ, Mattila K. Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis. J Clin Microbiol 2002, 40:4640-4645.
24. Gmur R, Baehni PC. Serum immunoglobulin G responses to various Actinobacillus actinomycetemcomitans serotypes in a young ethnographically heterogeneous periodontitis patient group. Oral Microbiol Immunol 1997, 12:1-10.
25. Tinoco EM, Lyngstadaas SP, Preus HR, Gjermo P. Attachment loss and serum antibody levels against autologous and reference strains of Actinobacillus actinomycetemcomitans in untreated localized juvenile periodontitis patients. J Clin Periodontol 1997, 24:937-944.
26. Kawamoto D, Ando ES, Longo PL, Nunes ACR, Wikstrom M, Mayer MPA. Genetic diversity and toxic activity of Aggregatibacter actinomycetemcomitans isolates. Oral Microbiol Immunol 2009, 24:493-501.
27. Albandar JM, DeNardin AM, Adesanya MR, Diehl SR, Winn DM. Associations between serum antibody levels to periodontal pathogens and early-onset periodontitis. J Periodontol 2001, 72:1463-1469.
28. Baker PJ, Wilson ME. Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. Oral Microbiol Immunol 1989, 4:98-105.
29. Wilson ME, Hamilton RG. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun 1995, 63:1062-1069.
30. Tsai CC, McArthur WP, Baehni PC, Evian C, Genco RJ, Taichman NS. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol 1981, 8:338-348.
31. Meyer DH, Mintz KP, Fives-Taylor PM. Models of invasion of enteric and periodontal pathogens into epithelial cells: a comparative analysis. Crit Rev Oral Biol Med 1997, 8:389-409.
32. Purven M, Frisk A, Lonnroth I, Lagergard T. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect Immun 1997, 65:3496-3499.
33. Lagergard T, Purven M. Neutralizing antibodies to Haemophilus ducreyi cytotoxin. Infect Immun 1997, 61:1589-1592.
34. Tan KS, Song KP, Ong G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans Occurrence and association with periodontal disease. J Periodontal Res 2002, 37:268-272.
35. Fabris AS, DiRienzo JM, Wikstrom M, Mayer MP. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol Immunol 2002, 17:231-238.
36. Yamano R, Ohara M, Nishikubo S. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J Clin Microbiol 2003, 41:1391-1398.
37. Belibasakis GN, Brage M, Lagergard T, Johansson A. Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. APMIS 2008, 116:499-506.
38. Johansson A, Buhlin K, Koski R, Gustafsson A. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis. Eur J Oral Sci 2005, 113:197-202.
39. Komatsuzawa H, Kawai T, Wilson ME, Taubman MA, Sugai M, Suginaka H. Cloning of the gene enconding the Actinobacillus actinomycetemcomitans serotype b OmpA-like outer membrane protein. Infect Immun 1999, 67:942-945.